VENTION ADVANCED TECHNOLOGIES acquired by NORDSON CORPORATION
Context
The acquisition of Vention Advanced Technologies by Nordson Corporation signifies a major step in the group’s expansion into the high-growth medtech sector. The strategic logic of this transaction hinges on a "market-balancing" maneuver, merging the target’s industry-leading technical operational depth in interventional delivery systems with the buyer’s established scale in precision fluid management. This alignment equips the combined organization with the scientific talent and manufacturing hardware necessary to address the increasing demand for minimally invasive medical solutions across North America, Europe, and Asia. This maneuver allows the organization to execute a definitive structural expansion of its technical suite, particularly in the single-use fluid management and biomaterial delivery segments.
VENTION ADVANCED TECHNOLOGIES, which reported an EBITDA margin of in 2017, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Healthcare & Pharma sector (15.6x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Vention Advanced Technologies is a Medical Components & Interventional Devices company based in Salem, New Hampshire, specializing in the technical development of minimally invasive delivery systems. The entity provides critical engineering solutions for the global medical technology industry, primarily focusing on the mechanical integrity of catheters, specialty medical tubing, and balloons. Rather than offering generic healthcare products, the firm operates a sophisticated manufacturing infrastructure dedicated to extrusion, nitinol forming, and complex component assembly. Its utility resides in its ability to support medical device manufacturers from initial design through full-scale industrial production.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (USD)
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 06/2017 | EQT PARTNERS | OTTOBOCK | GERMANY | Implants & Prosthetics |
| 05/2017 | PAI PARTNERS | ELITECH GROUP | FRANCE | Diagnostic Equipment |
| 04/2017 | BAIN CAPITAL / CINVEN | STADA | GERMANY | Generics / Labs |
| 03/2017 | ARDIAN | UNITHER | FRANCE | CDMO |
| 02/2017 | ECOLAB | LABORATOIRES ANIOS | FRANCE | Medical Consumables |
| 09/2016 | ARDIAN / IXO PRIVATE EQUITY | LAGARRIGUE | FRANCE | Implants & Prosthetics |
| 09/2016 | ARCHIMED | POLYPLUS | FRANCE | R&D Biotech |
| 06/2016 | PAI PARTNERS | ATOS MEDICAL | SWEDEN | Medical Consumables |
| 06/2016 | PAI PARTNERS | ETHYPHARM | FRANCE | Pharma & Biotech |
| 06/2016 | BRIDGEPOINT / RAISE / FLEXSTONE PARTNERS | ACTEON | FRANCE | Medical Devices |
REFERENCES
Valuation range: EV 500M - 1.5b USD
Revenue range: 100M - 200M USD
EBITDA range: 25M - 50M USD
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VENTION ADVANCED TECHNOLOGIES by NORDSON CORPORATION are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Acquirer: nordson corporation